Search & Analyze
Popular Searches
Sunrest Lifescience Ltd.
Trading₹35.00
CMP₹35.00
Mkt Cap₹15 Cr
P/E3.65
P/B0.92
ROE12.33%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
3.65
P/B Ratio
0.92
EV/EBITDA
1.99
Price/Sales
0.21
Dividend Yield (%)
0.00
EPS (TTM ₹)
9.59
Book Value (₹)
38.01
ROE (%)
12.33
ROCE (%)
10.33
ROA (%)
3.45
EBITDA Margin (%)
9.04
Net Profit Margin (%)
6.02
Debt/Equity
0.74
Current Ratio
1.73
Interest Coverage
9.58
Asset Turnover
0.57
Working Capital/Sales
1.48
Core EBITDA Growth (%)
0.00
P&L
| Particulars | FY 2024-25 (Mar) |
|---|---|
| Gross Sales | 3341.3 |
| Net Sales | 3341.3 |
| Total Income | 3341.75 |
| Total Expenditure | 3039.35 |
| Operating Profit | 302.4 |
| Depreciation | 9.5 |
| Exceptional Items | — |
| Profit Before Tax | 262.32 |
| Tax | 61.26 |
| Profit After Tax (PAT) | 201.06 |
| EPS (₹) | 4.67 |
| Dividend Payout % | — |
Balance Sheet
| Particulars | FY 2024-25 (Mar) |
|---|---|
| Share Capital | 429.12 |
| Reserves | 1201.97 |
| Shareholders Funds | 1631.09 |
| Total Debt | 1205.04 |
| Total Liabilities | 5824.4 |
| Total Assets | 5824.4 |
| Book Value / Share | 38.0101 |
| Assets | 5824.4 |
Cash Flows
| Particulars | FY 2024-25 (Mar) |
|---|---|
| Operating Activities | 292.08 |
| Investing Activities | -114.5 |
| Financing Activities | -32.72 |
| Net Cash Flow | 144.86 |
SUNREST
₹35.00
+0%